# Relapse and Functional Outcomes in Anti-LGI1 Encephalitis

> **NCT07722286** · — · COMPLETED · sponsor: **Shen Chun-Hong** · enrollment: 112 (actual)

## Conditions studied

- Autoimmune Encephalitis
- LGI1 Encephalitis
- Limbic Encephalitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07722286
- **Lead sponsor:** Shen Chun-Hong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2026-07-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07722286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07722286, "Relapse and Functional Outcomes in Anti-LGI1 Encephalitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07722286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*